ALPS Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $783K | Buy |
1,654
+745
| +82% | +$375K | ﹤0.01% | 619 |
|
|
2025
Q4 | $424K | Buy |
909
+94
| +12% | +$43.6K | ﹤0.01% | 857 |
|
|
2025
Q3 | $347K | Hold |
815
| – | – | ﹤0.01% | 935 |
|
|
2025
Q2 | $312K | Sell |
815
-517
| -39% | -$186K | ﹤0.01% | 926 |
|
|
2025
Q1 | $460K | Buy |
1,332
+413
| +45% | +$133K | ﹤0.01% | 604 |
|
|
2024
Q4 | $276K | Sell |
919
-855
| -48% | -$299K | ﹤0.01% | 938 |
|
|
2024
Q3 | $721K | Sell |
1,774
-414
| -19% | -$152K | ﹤0.01% | 563 |
|
|
2024
Q2 | $703K | Sell |
2,188
-151
| -6% | -$49.1K | ﹤0.01% | 529 |
|
|
2024
Q1 | $780K | Buy |
2,339
+399
| +21% | +$122K | 0.01% | 538 |
|
|
2023
Q4 | $525K | Hold |
1,940
| – | – | ﹤0.01% | 598 |
|
|
2023
Q3 | $477K | Buy |
1,940
+57
| +3% | +$15.6K | ﹤0.01% | 604 |
|
|
2023
Q2 | $571K | Buy |
1,883
+1,038
| +123% | +$289K | 0.01% | 588 |
|
|
2023
Q1 | $223K | Sell |
845
-355
| -30% | -$90.2K | ﹤0.01% | 971 |
|
|
2022
Q4 | $288K | Hold |
1,200
| – | – | ﹤0.01% | 911 |
|
|
2022
Q3 | $221K | Sell |
1,200
-101
| -8% | -$20.1K | ﹤0.01% | 992 |
|
|
2022
Q2 | $219K | Sell |
1,301
-1,798
| -58% | -$386K | ﹤0.01% | 979 |
|
|
2022
Q1 | $777K | Sell |
3,099
-13
| -0.4% | -$3.27K | 0.01% | 337 |
|
|
2021
Q4 | $800K | Buy |
3,112
+280
| +10% | +$68.5K | 0.01% | 391 |
|
|
2021
Q3 | $687K | Sell |
2,832
-401
| -12% | -$98K | 0.01% | 453 |
|
|
2021
Q2 | $668K | Buy |
3,233
+405
| +14% | +$82.5K | 0.01% | 482 |
|
|
2021
Q1 | $533K | Buy |
2,828
+549
| +24% | +$96.8K | 0.01% | 484 |
|
|
2020
Q4 | $375K | Buy |
2,279
+291
| +15% | +$42.5K | ﹤0.01% | 571 |
|
|
2020
Q3 | $248K | Sell |
1,988
-628
| -24% | -$77.7K | ﹤0.01% | 784 |
|
|
2020
Q2 | $254K | Sell |
2,616
-288
| -10% | -$29.9K | ﹤0.01% | 634 |
|
|
2020
Q1 | $261K | Buy |
2,904
+107
| +4% | +$13.9K | ﹤0.01% | 535 |
|
|
2019
Q4 | $413K | Sell |
2,797
-123
| -4% | -$16.5K | ﹤0.01% | 551 |
|
|
2019
Q3 | $352K | Buy |
+2,920
| New | +$377K | ﹤0.01% | 729 |
|
|
2018
Q3 | – | Sell |
-14,999
| Closed | -$1.54M | – | 1011 |
|
|
2018
Q2 | $1.54M | Buy |
14,999
+9,449
| +170% | +$956K | 0.01% | 256 |
|
|
2018
Q1 | $538K | Buy |
+5,550
| New | +$538K | ﹤0.01% | 475 |
|
|
2016
Q3 | – | Sell |
-5,580
| Closed | -$430K | – | 713 |
|
|
2016
Q2 | $430K | Sell |
5,580
-252
| -4% | -$19.9K | ﹤0.01% | 375 |
|
|
2016
Q1 | $455K | Buy |
+5,832
| New | +$407K | ﹤0.01% | 329 |
|
|
2015
Q1 | – | Sell |
-7,312
| Closed | -$537K | – | 708 |
|
|
2014
Q4 | $537K | Sell |
7,312
-988
| -12% | -$69.4K | ﹤0.01% | 413 |
|
|
2014
Q3 | $585K | Buy |
+8,300
| New | +$549K | ﹤0.01% | 349 |
|
Other funds holding HCA
VCM
VPM
ALPS Advisors's HCA Position: Q1 2026 in Review
ALPS Advisors increased its HCA Healthcare (HCA) stake by 82% in Q1 2026, buying an estimated $375K and bringing the position to 1,654 shares worth $783K. The position accounts for ﹤0.01% of the portfolio, ranked #619.
ALPS Advisors first reported a position in HCA in Q3 2014 and has held it in 33 quarters since. The position peaked at $1.54M in Q2 2018. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- ALPS Advisors held 1,654 shares of HCA Healthcare worth $783K as of Q1 2026.
- ALPS Advisors bought 745 HCA Healthcare shares in Q1 2026, an estimated $375K.
- HCA Healthcare made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #619 holding.
- ALPS Advisors first reported a position in HCA Healthcare in Q3 2014 and has held it in 33 quarters since.
- ALPS Advisors's HCA Healthcare position peaked at $1.54M in Q2 2018.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.